Projecten per jaar
Persoonlijk profiel
Expertise
I obtained my master in Biomedical Sciences from the Vrije Universiteit Brussel (VUB) in 2014. In 2014, I started my PhD under the supervision of Prof. Nick Devoogdt in the In vivo Cellular and Molecular Imaging (ICMI) lab, VUB. During my PhD, I have been focusing on evaluating the potential of radiolabeled single domain antibody fragments for radionuclide-based imaging and targeted radionuclide therapy of Non-Hodgkin lymphoma. I defended my PhD in 2019. As a postdoctoral researcher, my interest is on the investigation of the effects on the immune response after targeted radiation of cancer cells.
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Ahmet Krasniqi actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
IWT710: Gerichte radionuclidentherapie van non-hodgkin lymfoom met anti-CD20 nanobodies
1/01/15 → 31/12/18
Project: Fundamenteel
-
BRGRD36: Joint R&D Project: Invigorating precision medicine by predictive imaging of SDAB-based anti-cancer theranostics
Keyaerts, M., Breckpot, K. & Krasniqi, A.
1/01/70 → 4/10/19
Project: Fundamenteel
Onderzoeksoutput
-
Emerging applications of nanobodies in cancer therapy
Awad, R. M., Meeus, F., Ceuppens, H., Ertveldt, T., Hanssens, H., Lecocq, Q., Mateusiak, L., Zeven, K., Valenta, H., De Groof, T. W. M., De Vlaeminck, Y., Krasniqi, A., De Veirman, K., Goyvaerts, C., D'Huyvetter, M., Hernot, S., Devoogdt, N. & Breckpot, K., 2022, In: International review of cell and molecular biology. 369, blz. 143-199 57 blz.Onderzoeksoutput: Article › peer review
Bestand1 Citaat (Scopus)53 Downloads (Pure) -
Radiotheranostic Agents in Hematological Malignancies
Caers, J., Duray, E., Vrancken, L., Marcion, G., Bocuzzi, V., De Veirman, K., Krasniqi, A., Lejeune, M., Withofs, N., Devoogdt, N., Dumoulin, M., Karlström, A. E. & D'Huyvetter, M., 5 jul 2022, In: Frontiers in Immunology. 13, 18 blz., 911080.Onderzoeksoutput: Article › peer review
Open Access1 Citaat (Scopus) -
Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model
Ertveldt, T., De Beck, L., De Ridder, K., Locy, H., De Mey, W., Goyvaerts, C., Lecocq, Q., Ceuppens, H., De Vlaeminck, Y., Awad, R. M., Keyaerts, M., Devoogdt, N., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., jul 2022, In: Molecular Cancer Therapeutics. 21, 7, blz. 1136-1148 13 blz.Onderzoeksoutput: Article › peer review
Open Access -
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma
Duray, E., Lejeune, M., Baron, F., Beguin, Y., Devoogdt, N., Krasniqi, A., Lauwers, Y., Zhao, Y. J., D'Huyvetter, M., Dumoulin, M. & Caers, J., 2 nov 2021, In: Journal of Hematology & Oncology. 14, 1, 13 blz., 183.Onderzoeksoutput: Article › peer review
Open AccessBestand7 Citaten (Scopus)22 Downloads (Pure) -
CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma
De Veirman, K., Puttemans, J., Krasniqi, A., Ertveldt, T., Hanssens, H., Romao, E., Hose, D., Goyvaert, C., Vlummens, P., Muyldermans, S., Breckpot, K., Bruchertseifer, F., Morgenstern, A., D'Huyvetter, M. & Devoogdt, N., 2021, In: Oncoimmunology. 10, 1, 11 blz., 2000699.Onderzoeksoutput: Article › peer review
Open Access4 Citaten (Scopus)
Prijzen
-
Alavi-Mandell Award from Journal of Nuclear Medicine
Krasniqi, Ahmet (Recipient), D'Huyvetter, Matthias (Recipient), Devoogdt, Nick (Recipient) & Keyaerts, Marleen (Recipient), 16 apr 2019
Prijs: Prize (including medals and awards)
-
Travel Stipend WMIC 2016 - Best Preclinical Paper
Krasniqi, Ahmet (Recipient), sep 2016
Prijs: Prize (including medals and awards)
-
2020-69
Marleen Keyaerts (Supervisor), Ahmet Krasniqi (Contributor), Cindy Peleman (Contributor), Kevin De Jonghe (Contributor) & Yoline Lauwers (Contributor)
2020Activiteit: Other
-
2020-78
Nick Devoogdt (Supervisor), Marleen Keyaerts (Supervisor) & Ahmet Krasniqi (Contributor)
2020 → …Activiteit: Other
-
Targeted radionuclide therapy of Non-Hodgkin lymphoma with theranostic anti-hCD20 Nb
Ahmet Krasniqi (Speaker), Matthias D'Huyvetter (Contributor), Catarina Xavier (Contributor), Kevin Van Der Jeught (Contributor), Serge Muyldermans (Contributor), Tony Lahoutte (Contributor), Jan Tavernier (Contributor) & Nick Devoogdt (Contributor)
28 mrt 2017Activiteit: Talk or presentation at a conference
-
Targeted radionuclide therapy of Non-Hodgkin lymphoma with 177Lu-radiolabeled anti-hCD20 Nb
Ahmet Krasniqi (Speaker), Matthias D'Huyvetter (Contributor), Catarina Xavier (Contributor), Kevin Van Der Jeught (Contributor), Serge Muyldermans (Contributor), Tony Lahoutte (Contributor), Jan Tavernier (Contributor) & Nick Devoogdt (Contributor)
16 mei 2017Activiteit: Talk or presentation at a conference
-
Forethought on Using Macrophage Mannose Receptor as Target in Atherosclerosis
Gezim Bala (Contributor), Henri Vincent Baudhuin (Contributor), Kris Gillis (Contributor), Isabel Remory (Contributor), Ahmet Krasniqi (Contributor), Tony Lahoutte (Contributor), Nick Devoogdt (Contributor), Steven Droogmans (Contributor), Bernard Cosyns (Contributor) & Sophie Hernot (Speaker)
3 feb 2016Activiteit: Talk or presentation at a conference
Scriptie
-
Targeted radionuclide therapy of non-Hodgkin lymphoma with anti-CD20 single domain antibody fragments.
Auteur: Krasniqi, A., Devoogdt, N., D'Huyvetter, M., Tavernier, J., Pouget, J., Caers, J., Breckpot, K., Laoui, D. & Neyns, B., 24 mei 2019Begeleider: Devoogdt, N. (Promotor), D'Huyvetter, M. (Promotor), Tavernier, J. (Externe persoon) (Co-promotor), Pouget, J. (Externe persoon) (Jury), Caers, J. (Externe persoon) (Jury), Breckpot, K. (Jury), Laoui, D. (Jury) & Neyns, B. (Jury)
Scriptie/Masterproef: Doctoral Thesis